Manuscripts

Abstracts

June 3, 2022

The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer

ASCO Annual Meeting 2022
Johnson K et al
June 3, 2022

Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data

ASCO Annual Meeting 2022
Behera M et al
June 3, 2022

Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ Discovery (CLQD) data

ASCO Annual Meeting 2022
Mileham KF et al
June 3, 2022

Natural language processing-optimized case selection for real world evidence studies

ASCO Annual Meeting 2022
Koskimaki J et al
September 8, 2021

Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

World Conference on Lung Cancer 2021
Behera M et al
September 24, 2021

Development of a breast cancer-specific prognostic tool using CancerLinQ Discovery

ASCO Quality Care Symposium 2021
Ray E et al
September 24, 2021

Survival in the Real World: A National Analysis of Patients Treated for Early Stage Breast Cancer

ASCO Quality Care Symposium 2021
Franks J et al
September 24, 2021

Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery (CLQD) Analysis

ASCO Quality Care Symposium 2021

Rocque G et al

August 25, 2021

The Friends of Cancer Research Real World Data (RWD) Pilot 2.0 Collaboration: Implementation of Standardized Methodological Approaches for Evaluation of Oncology RWD

ICPE Annual Conference 2021
Rivera D et al